Overview

Bupivacaine Versus Lidocaine on Inflammatory Regulation

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicine at the end of root canal surgery. Small pieces of gum will be taken before and after surgery and 2 days later to analyze chemicals that may be related to pain sensation.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland
University of Maryland, College Park
Treatments:
Bupivacaine
Lidocaine